Stock overview
BridgeBio Pharma Inc.
Explore the company, reported ownership, price history, and available source evidence.
BridgeBio Pharma Inc. (BBIO) is a healthcare or biotechnology equity security tracked from 13F filings.
- Last close
- $65.57
- · BBIO
- Tracked holders
- 5 funds
- Latest available 13F per fund
BBIO · USD
Price
$65.57
+$16.57
(+33.82%)
over selected range
Close · Sep 25, 2026
Market closed
252 stored daily closes
$65.57
Sep 25, 2026
- Range low
- $49.00
- Range high
- $90.17
- Observations
- 252
- Session date
- Sep 25, 2026
Sep 25, 2025–Sep 25, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Viking Global Investors largest tracked holder Q2 2026 · filed Aug 14, 2026 · SEC filing | −16% 26'Q2 | $741,017,831 | 2.11% |
| Sequoia Capital position history Q2 2026 · filed Aug 14, 2026 · SEC filing | — | $138,559,911 | 0.43% |
| Renaissance Technologies position history Q2 2026 · filed Aug 13, 2026 · SEC filing | +134% 26'Q2 | $63,817,890 | 0.09% |
| Tudor Investment Corp position history Q2 2026 · filed Aug 14, 2026 · SEC filing | Newly reported 26'Q2 | $5,747,622 | 0.01% |
| Polen Capital Management position history Q2 2026 · filed Aug 4, 2026 · SEC filing | −91% 26'Q2 | $298,069 | 0% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market